Skip to main content
H.R. 4115 118th Congress House

Lower Drug Costs for Families Act

Official title: To amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations.

Introduced: June 14, 2023 Introduced by: Ruben Gallego Democratic · Arizona See on congress.gov
Health Government information and archivesHealth care costs and insuranceMedicarePrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jun 16, 2023
Referred to the Subcommittee on Health.
Jun 14, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 14, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Lower Drug Costs for Families Act

This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.

Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.

The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).

 Related & companion bills 1
  • S 1139 Identical bill Lower Drug Costs for Families Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 2
D
Horsford, Steven
Nevada · Mar 19, 2024
 D
Slotkin, Elissa
Michigan · Jun 14, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4115: Lower Drug Costs for Families Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-4115/
MLA
"H.R. 4115: Lower Drug Costs for Families Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-4115/.
Bluebook (legal)
H.R. 4115, 118th Cong. (2026), https://openamerica.io/bill/118-HR-4115/.
Markdown link
[H.R. 4115: Lower Drug Costs for Families Act](https://openamerica.io/bill/118-HR-4115/)
Report a problem